Navigation Links
Kensey Nash Reports Fourth Quarter and Fiscal Year 2008 Results
Date:8/21/2008

%

Supplemental Information

related to Equity Compensation

Expense:

Equity Compensation Expense $0.7 $0.5

Equity Compensation Expense

Per Share (net of tax) $0.04 $0.03

Fiscal Year 2008 Results

Revenues: Sales and Royalties. Total revenues for the fiscal year ended June 30, 2008 were $79.8 million, up 15% from total revenues of $69.5 million for the fiscal year ended June 30, 2007.

Net sales increased 20% to $53.8 million from $44.9 million recorded in the prior fiscal year. Net sales of biomaterials products increased 16% to $47.5 million from $41.1 million, primarily due to orthopaedic product sales, which increased 35% to $29.4 million from $21.8 million. Sports medicine and spine product sales increased, 27% and 47%, respectively, over the prior fiscal year period. Sports medicine product sales were led by a 27% increase in product sales to the Company's most significant customer in this market. The increase in spine product sales included $2.0 million of new product sales resulting from the Company's MacroPore Biosurgery asset acquisition, completed in May 2007. Sales to Orthovita increased $1.9 million due to strong end user sales of existing products and initial shipments for the new VITOSS(R) Bioactive Foam product line launched by Orthovita in the second calendar quarter of 2008. Sales of vascular closure product components to St. Jude Medical decreased $1.8 million, or 10%, from the prior year period, as anticipated and previously disclosed.

Sales of endovascular products during the 2008 fiscal year increased 64% to $6.2 million from $3.8 million in the prior year. Endovascular sales included direct sales to customers through the month of May, as well as sales of product to Spectranetics during the month of June, after the Company's completion of the sale of its endovascular business (see below).

Royalty income for the fiscal year increased
'/>"/>

SOURCE Kensey Nash Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21

Related biology technology :

1. Kensey Nash Corporation Announces Its Third Quarter 2008 Earnings Release Date and Teleconference
2. Kensey Nash Receives FDA 510(k) Clearance for New Safe-Cross(R) Vessel Wall Detection Technology
3. Kensey Nash to Present at the Canaccord Adams Small-Cap Orthopedics Conference
4. Kensey Nash to Participate in the Sidoti Fifth Annual Palm Beach Emerging Growth Institutional Investor Forum Conference
5. Kensey Nash to Participate in the RBC Capital Markets Healthcare Conference
6. Kensey Nash to Present at the Sidoti Sixth Annual West Coast Emerging Growth Institutional Investor Forum Conference
7. InstaCare Corp. Continues Turnaround & Reports 291% Revenues Increase in 2Q 2008
8. CEL-SCI CORPORATION Reports Third Quarter 2008 Financial Results
9. Expert Neurology Panel Weighs Impact of New Reports of PML in Multiple Sclerosis Patients on Tysabri
10. Arpida Reports Interim Results for Six Months to 30 June 2008
11. Rosetta Genomics Reports Second Quarter 2008 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/24/2014)... (PRWEB) July 24, 2014 2014 ... Sulphate Industry” is a professional and in-depth research ... introduces Potassium Sulphate basic information, including its ... industry overview. This research covers the international market ... global industry analysis covering macroeconomic environment & economic ...
(Date:7/24/2014)... 2014  Neogen Corporation (Nasdaq: NEOG ) ... potential revenue from new rodenticide research are premature. In ... on July 22, 2014, Neogen,s CEO commented about several ... "It was my intent Tuesday at our ... a new type of rodenticide, but certainly not to ...
(Date:7/24/2014)... 24, 2014 WIRB-Copernicus Group ® ... ethical review services for clinical research, announced today ... division of Richmond, VA -based ... and biosecurity consulting firm in the ... biosafety division – WCG Biosafety™ – will be ...
(Date:7/24/2014)... 1000 balances – 4 steps – One ... needs and expertly narrows down the mass of product ... even terminals. , First, select the working environment, ... readability instead) and define the accuracy – it’s really ... down the list to models that fit best with ...
Breaking Biology Technology:Potassium Sulphate Market & SHMP Industry 2014 (Global, China) Analysis Now Available at DeepResearchReports.com 2Potassium Sulphate Market & SHMP Industry 2014 (Global, China) Analysis Now Available at DeepResearchReports.com 3Potassium Sulphate Market & SHMP Industry 2014 (Global, China) Analysis Now Available at DeepResearchReports.com 4Neogen comments on SenesTech 2WIRB-Copernicus Group Announces Acquisition of Alliance Biosciences; Executives Join WCG Biosafety Division 2WIRB-Copernicus Group Announces Acquisition of Alliance Biosciences; Executives Join WCG Biosafety Division 3
... Fund More Than Doubles Assets Under Management, UTRECHT, ... growing European venture capital firm, today announced,the closing of ... Gilde,Healthcare II (GHC II). The new fund, which is ... funds raised to invest in European,healthcare opportunities. GHC II ...
... Emerging Nanotechnologies will host the U.S. launch of ... Responsible Nanotechnology aimed principally at businesses and research ... Society and the United Kingdom government-sponsored Nanotechnology Knowledge ... Association, Insight Investment. , The event ...
... Genmab Antibody,Summary: Genmab,s Partner Roche has Filed a CTA With the ... ... COPENHAGEN, October 2 Genmab A/S (OMX: GEN),announced today that ... British Medicines and Healthcare products,Regulatory Agency (MHRA) for a Genmab antibody ...
Cached Biology Technology:Gilde Healthcare Partners Closes EUR 150 Million European Healthcare Venture Fund 2A new 'responsible nanocode' for business 2Genmab A/S - Company Announcement 2
(Date:7/24/2014)... This news release is available in German . ... has evolved to recognize and respond to threats to ... disease. A detailed understanding of the mechanism underlying immunologic ... of research have converged to support the hypothesis that ... of immune cells with stem-cell-like potential. Until now, there ...
(Date:7/24/2014)... 2014 NXT-ID, Inc., (NXTD: OTCQB) a biometric authentication company ... smart wallet, Wocket™, was recently the topic of  an interview ... Gino Pereira , CEO of NXT-ID, on July ... Mr. Gino Pereira explains how the ... cards and walks host Anita Finley through ...
(Date:7/24/2014)... Odds are, theres a virus living inside your gut ... new study led by researchers at San Diego State ... population is host to a newly described virus, named ... of gut bacteria, Bacteroidetes . This phylum of ... and other gut-related diseases. The research appears today in ...
Breaking Biology News(10 mins):Experiments prove 'stemness' of individual immune memory cells 2Experiments prove 'stemness' of individual immune memory cells 3Boomer Times Gets to Know NXT-ID's Next Generation Wocket Smart Wallet; Practical, Secure and Easy to Use 2Boomer Times Gets to Know NXT-ID's Next Generation Wocket Smart Wallet; Practical, Secure and Easy to Use 3Boomer Times Gets to Know NXT-ID's Next Generation Wocket Smart Wallet; Practical, Secure and Easy to Use 4Newly discovered gut virus lives in half the world's population 2Newly discovered gut virus lives in half the world's population 3
... has destroyed 17 percent of the native vegetation in ... new study published by Conservation International sounds an alarm ... Continued deforestation at the current rate would cause all ... years, according to CI researchers in Brazil. , Overall, ...
... It's one of those unavoidable facts of life -- ... internal temperatures cause only temporary discomfort, but in some ... , These convulsions are "scary and very upsetting to ... chair of Neurology. They've also been something of an ...
... shows that robot assisted knee surgery is significantly ... of surgeons tested whether Acrobot, a robotic assistant, ... knee replacement. Acrobot works by helping the surgeon ... the existing bones. , The surgeons looked at ...
Cached Biology News:Report shows deforestation threatens Brazil's Pantanal 2Molecular mechanism may explain how fevers spark seizures 2Molecular mechanism may explain how fevers spark seizures 3Robot assisted surgery more accurate than conventional surgery 2
Spectrolyse (pL) PAI kit is a two-stage indirect enzymatic assay for the quantitative determination of Plasminogen Activator Inhibitor (PAI-1) activity in plasma. Sample Type: plasma...
NAK/TBK1 (CT) Affinity Purified Polyclonal Antibody...
... human cardiac troponin subunit T, a 31kDa protein ... contraction of cardiac muscle. It reacts with subunit ... It also cross-reacts with human skeletal troponin T ... Highly purified human cardiac troponin T ...
... is pleased to offer the ATTO-TAG ... detection of primary amines. Developed by ... the ATTO-TAG reagents are similar to ... (NDA) and anthracene-2,3-dicarboxaldehyde, all of which ...
Biology Products: